Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
In our study, early remdesivir administration was not associated with preventing progression to severe disease when used as previously indicated during the Omicron wave. Considering the decline in the severity of the Omicron variant and the increased vaccination rate reported in previous studies, further studies are needed to establish new indications for the use of early remdesivir in the Omicron variant.
Authors
- Yeonju La (ORCID: https://orcid.org/0000-0003-2314-3699)
- Yong Duk Jeon (ORCID: https://orcid.org/0000-0002-4588-4781)
- Myoung-Nam Lim (ORCID: https://orcid.org/0000-0003-3562-0667)
- Changhyup Kim
- Won Sup Oh (ORCID: https://orcid.org/0000-0002-4992-4787)
Institutions
- Kangwon National University (KR)
- Kangwon National University Hospital (KR)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1186/s12879-025-10585-3
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Kangwon National University